<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03508505</url>
  </required_header>
  <id_info>
    <org_study_id>T3/2018</org_study_id>
    <nct_id>NCT03508505</nct_id>
  </id_info>
  <brief_title>Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation</brief_title>
  <acronym>PC-ECMO</acronym>
  <official_title>Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedali Riuniti Trieste</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universit√§tsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Burgundy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henri Mondor University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Glenfield Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS Azienda Ospedaliero-Universitaria di Bologna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute for Clinical and Experimental Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Udine, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Golden Jubilee National Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helios Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lund University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Prince Sultan Cardiac Center, Adult Cardiology Department.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac surgery can be not infrequently complicated by cardiac low-output syndrome due to&#xD;
      critical preoperative conditions such as cardiogenic shock, poor left ventricular function&#xD;
      and severe myocardial ischemia. Suboptimal myocardial protection, technical errors at graft&#xD;
      anastomoses or of prosthesis implantation, and hibernating myocardium may further contribute&#xD;
      to cardiac low-output syndrome occurring immediately or shortly after cardiac surgery. In&#xD;
      this setting, veno-arterial extracorporeal oxygenation (VA-ECMO) is the only means to provide&#xD;
      cardiopulmonary support to recovery or as bridge to transplantation.&#xD;
&#xD;
      Data on the real benefit of VA-ECMO after cardiac surgery is limited and often derived from&#xD;
      heterogeneous patient populations, which prevent conclusive results on the benefits of&#xD;
      VA-ECMO in this setting. This issue will be investigated in the present retrospective&#xD;
      European multicenter study.&#xD;
&#xD;
      In this setting, veno-arterial extracorporeal oxygenation (VA-ECMO) is the only means to&#xD;
      provide cardiopulmonary support to recovery or as bridge to transplantation.&#xD;
&#xD;
      Data on the real benefit of VA-ECMO after cardiac surgery is limited and often derived from&#xD;
      heterogeneous populations of patients who underwent different cardiac procedures. Patients&#xD;
      with cardiac low-output after surgery for aortic dissection or valve surgery are expected to&#xD;
      have different baseline characteristics (such as age and comorbidities) and underlying&#xD;
      cardiac disease than patients undergoing isolated coronary surgery. Furthermore, available&#xD;
      studies included patients operated two decades ago and this does not provide an exact measure&#xD;
      of the benefits of this treatment strategy.&#xD;
&#xD;
      The possible benefits of using VA-ECMO after adult cardiac surgery will be investigated in&#xD;
      this retrospective European multicenter study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac surgery can be not infrequently complicated by cardiac low-output syndrome due to&#xD;
      critical preoperative conditions such as cardiogenic shock, poor left ventricular function&#xD;
      and severe myocardial ischemia. Prolonged aortic cross-clamping, ischemia-reperfusion injury,&#xD;
      suboptimal myocardial protection, technical errors at graft anastomoses or of prosthesis&#xD;
      implantation, and hibernating myocardium may further contribute to cardiac low-output&#xD;
      syndrome occurring immediately or shortly after cardiac surgery. In this setting,&#xD;
      veno-arterial extracorporeal oxygenation (VA-ECMO) is the only means to provide&#xD;
      cardiopulmonary support to recovery or as bridge to transplantation.&#xD;
&#xD;
      Data on the real benefit of VA-ECMO after cardiac surgery is limited and often derived from&#xD;
      heterogeneous and small size series of patients who underwent different cardiac surgery&#xD;
      procedures. Patients with cardiac low-output after surgery for aortic dissection or valve&#xD;
      surgery are expected to have different baseline characteristics (such as age and&#xD;
      comorbidities) and underlying cardiac disease than patients undergoing isolated coronary&#xD;
      surgery. Furthermore, available studies included patients operated two decades ago and, in&#xD;
      view of the development of perfusion technology and perioperative care, this does not provide&#xD;
      an exact measure of the current benefits of this treatment strategy. Importantly, the role of&#xD;
      intra-aortic balloon pump, left ventricular venting, duration of VA-ECMO and hospital&#xD;
      experience should be evaluated. The investigators sought to investigate these issues in a&#xD;
      large multicenter study.&#xD;
&#xD;
      Patients and methods Patients who were treated with VA-ECMO for cardiac low-output after&#xD;
      adult cardiac surgery (other than heart transplantation and/or implantation of a left&#xD;
      ventricular assist device) in 21 centers of cardiac surgery from January 2010 to December&#xD;
      2017.&#xD;
&#xD;
      Eligibility criteria&#xD;
&#xD;
        -  Patients aged &gt; 18 years;&#xD;
&#xD;
        -  Patients who required VA-ECMO after elective, urgent or emergency adult cardiac surgery&#xD;
           such as coronary surgery, heart valve surgery and/or aortic root surgery because of&#xD;
           postoperative low-cardiac output syndrome and/or acute respiratory failure.&#xD;
&#xD;
      Exclusion criteria&#xD;
&#xD;
        -  Patients aged &lt; 18 years;&#xD;
&#xD;
        -  Any VA-ECMO implanted before index surgical procedure;&#xD;
&#xD;
        -  Patients who underwent postoperatively veno-venous ECMO;&#xD;
&#xD;
        -  Patients who required VA-ECMO after heart transplantation;&#xD;
&#xD;
        -  Patients who required VA-ECMO after any left ventricular assist device.&#xD;
&#xD;
      Definition criteria Definition criteria and units of measurements are reported beside each&#xD;
      baseline, operative and postoperative variables in the electronic datasheet.&#xD;
&#xD;
      Outcomes&#xD;
&#xD;
        1. Hospital death&#xD;
&#xD;
        2. Late death&#xD;
&#xD;
        3. Stroke&#xD;
&#xD;
        4. Tracheostomy&#xD;
&#xD;
        5. Gastrointestinal complications&#xD;
&#xD;
        6. Deep sternal wound infection&#xD;
&#xD;
        7. Vascular access site infection&#xD;
&#xD;
        8. Blood stream infection&#xD;
&#xD;
        9. Peripheral vascular injury&#xD;
&#xD;
       10. Major lower limb amputation&#xD;
&#xD;
       11. New onset dialysis&#xD;
&#xD;
       12. Peak postoperative serum creatinine level&#xD;
&#xD;
       13. Nadir postoperative pH during VA-ECMO&#xD;
&#xD;
       14. Peak postoperative arterial lactate level&#xD;
&#xD;
       15. Nadir postoperative hemoglobin level&#xD;
&#xD;
       16. Chest drainage output 24 h after surgery&#xD;
&#xD;
       17. Number of red blood cells units transfused intra- and postoperatively&#xD;
&#xD;
       18. Reoperation for intrathoracic bleeding&#xD;
&#xD;
       19. Reoperation for peripheral cannulation-related bleeding&#xD;
&#xD;
       20. Intensive care unit length of stay&#xD;
&#xD;
       21. Death on VA-ECMO&#xD;
&#xD;
      Analysis of clinical results&#xD;
&#xD;
      The aim of this registry is to perform a number of analysis evaluating:&#xD;
&#xD;
        1. Early and late survival of postcardiotomy VA-ECMO;&#xD;
&#xD;
        2. Predictors and causes of in-hospital death after successful weaning from postcardiotomy&#xD;
           VA-ECMO;&#xD;
&#xD;
        3. Comparative analysis of peripheral versus central postcardiotomy VA-ECMO;&#xD;
&#xD;
        4. VA-ECMO plus intra-aortic baloon pump vs. isolated VA-ECMO;&#xD;
&#xD;
        5. Determinants of outcome after prolonged postcardiotomy VA-ECMO (&gt;5 days).&#xD;
&#xD;
      Publication of results The results of these studies will be submitted for publication to&#xD;
      international, peer-reviewed journals in the fields of critical care, cardiology or cardiac&#xD;
      surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital death</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>All-cause death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Late death</measure>
    <time_frame>Up to 7-year follow-up after the index cardiac surgery</time_frame>
    <description>All-cause death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Ischemic infarction or hemorrhagic injury of the brain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tracheostomy</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Respiratory failure requiring tracheostomy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal complications</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Gastrointestinal complications requiring surgical treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deep sternal wound infection</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Deep sternal wound infection or mediastinitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular access site infection</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Infection secondary to any vascular access</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood stream infection</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Blood stream infection detected at blood cultures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral vascular injury</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Any aortic and/or peripheral artery complications related to VA-ECMO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major lower limb amputation</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Major lower limb amputation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New onset dialysis</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>New onset dialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak postoperative serum creatinine level</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Peak postoperative serum creatinine level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nadir postoperative pH during VA-ECMO</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Nadir postoperative pH during VA-ECMO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak postoperative arterial lactate level</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Peak postoperative arterial lactate level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nadir postoperative hemoglobin level</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Nadir postoperative hemoglobin level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chest drainage output 24 h after surgery</measure>
    <time_frame>Up to 24 hours after the index cardiac surgery</time_frame>
    <description>Chest drainage output 24 h after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of red blood cells units transfused intra- and postoperatively</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Number of red blood cells units transfused intra- and postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperation for intrathoracic bleeding</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Reoperation for intrathoracic bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperation for peripheral cannulation-related bleeding</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Reoperation for peripheral cannulation-related bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive care unit length of stay</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Intensive care unit length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death on VA-ECMO</measure>
    <time_frame>Up to 30 days after the index cardiac surgery</time_frame>
    <description>Death on VA-ECMO</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Acute Heart Failure</condition>
  <condition>Low Output Heart Failure</condition>
  <condition>Cardiac Output, Low</condition>
  <condition>Extracorporeal Membrane Oxygenation</condition>
  <condition>Cardiac Surgery</condition>
  <condition>Venoarterial Extracorporeal Membrane Oxygenation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Venoarterial extracorporeal oxygenation</intervention_name>
    <description>Veno-arterial extracorporeal oxygenation (VA-ECMO) is inserted in the acute setting in case of cardiac low output after adult cardiac surgery in order to provide cardiopulmonary support to recovery or as bridge to transplantation.</description>
    <other_name>Cardiac surgery</other_name>
    <other_name>Coronary artery bypass grafting</other_name>
    <other_name>Aortic valve replacement</other_name>
    <other_name>Mitral valve repair</other_name>
    <other_name>Aortic surgery</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who required VA-ECMO for acute heart failure occurring during the index&#xD;
        hopsitalization for elective, urgent or emergency adult cardiac surgery such as coronary&#xD;
        surgery, heart valve surgery and/or aortic root surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who required VA-ECMO after elective, urgent or emergency adult cardiac&#xD;
             surgery such as coronary surgery, heart valve surgery and/or aortic root surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any VA-ECMO implanted before index surgical procedure;&#xD;
&#xD;
          -  Patients who underwent postoperatively veno-venous ECMO;&#xD;
&#xD;
          -  Patients who required VA-ECMO after heart transplantation;&#xD;
&#xD;
          -  Patients who required VA-ECMO after any left ventricular assist device.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Heart Center, Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 6, 2018</study_first_submitted>
  <study_first_submitted_qc>April 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2018</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Heart Failure</keyword>
  <keyword>Low Output Heart Failure</keyword>
  <keyword>Cardiac Low Output</keyword>
  <keyword>Extracorporeal Membrane Oxygenation</keyword>
  <keyword>ECMO</keyword>
  <keyword>Venoarterial Extracorporeal membrane oxygenation</keyword>
  <keyword>Cardiac Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiac Output, Low</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Upon request, the investigators will ask the Ethical Committee of the participating centers for permission to share all individual participant data included in this registry with the exception of data through which the patients could be identified.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

